New atpenins, NBRI23477 A and B, inhibit the growth of human prostate cancer cells

The Journal of Antibiotics
2009.0

Abstract

The growth and metastasis of prostate cancer are regulated by prostate stroma through the tumor-stromal cell interactions. Small molecules that modulate the tumor-stromal cell interactions will be new anticancer drugs. In the course of our screening of the modulators, we isolated two new atpenins, NBRI23477 A (4) and B (5), from the fermentation broth of Penicillium atramentosum PF1420. Compounds 4 and 5 as well as atpenin A4 (1), A5 (2) and B (3) inhibited the growth of human prostate cancer DU-145 cells in the coculture with human prostate stromal cells more strongly than that of DU-145 cells alone.

Knowledge Graph

Similar Paper

New atpenins, NBRI23477 A and B, inhibit the growth of human prostate cancer cells
The Journal of Antibiotics 2009.0
NBRI16716A, a new antitumor compound against human prostate cancer cells, produced by Perisporiopsis melioloides Mer-f16716
The Journal of Antibiotics 2010.0
JBIR-120: a new growth inhibitor of hormone-refractory prostate cancer cells
The Journal of Antibiotics 2012.0
17(E)-Picolinylidene androstane derivatives as potential inhibitors of prostate cancer cell growth: Antiproliferative activity and molecular docking studies
Bioorganic & Medicinal Chemistry 2013.0
Atpenins, new antifungal antibiotics produced by Penicillium sp. Production, isolation, physico-chemical and biological properties.
The Journal of Antibiotics 1988.0
Discovery and Structure-Based Optimization of Novel Atg4B Inhibitors for the Treatment of Castration-Resistant Prostate Cancer
Journal of Medicinal Chemistry 2022.0
Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2
The Journal of Antibiotics 2013.0
Stephacidin A and B:  Two Structurally Novel, Selective Inhibitors of the Testosterone-Dependent Prostate LNCaP Cells
Journal of the American Chemical Society 2002.0
Four new antitumor metabolites isolated from a mutant 3-f-31 strain derived from Penicillium purpurogenum G59
European Journal of Medicinal Chemistry 2018.0
Four new antitumor metabolites isolated from a mutant 3-f-31 strain derived from Penicillium purpurogenum G59
European Journal of Medicinal Chemistry 2018.0